Gene test before kidney transplant could prevent drug dosing errors
NCT ID NCT06701825
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests whether checking a patient's genes before a kidney transplant helps doctors give the right dose of tacrolimus, a drug that prevents organ rejection. About 114 people waiting for a kidney transplant will be randomly assigned to either genetic testing or standard care. The goal is to see if the genetic approach leads to better drug levels in the blood, fewer rejections, and lower costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital La Paz
RECRUITINGMadrid, Madrid, 28046, Spain
Contact
Conditions
Explore the condition pages connected to this study.